制药 产业/市场情报数据

Congestive Heart Failure: Major World Markets, Volume I: Pharmaceutical Management

Dealmaking and Financing: Buying in Innovation

Drug Delivery Systems

Emerging Pharmaceutical markets Argentina and Mexico

GLUCOSAMINE - A MARKET INSIGHT REPORT

Health and Wellness Healthcare in the United Kingdom

Health and Wellness Healthcare in the US

Impact of Pharmacogenomics on Public Healthcare Policy: Educating patients, payors and healthcare providers

Improving Efficiencies through the Development of Claims Processing in Healthcare (Strategic Focus)

In Vitro Diagnostics Market Profile: Detailed Analysis of the Medical Equipment Market Covering Medical Devices, Biomedical Devices, Healthcare Appliances and Medical Supplies.

Indian Contract Manufacturing - A Hot Opportunity

Indian Generics, 2008-2012 The Growing Threat to Westernised Markets

Intravenous Solutions - A MARKET INSIGHT REPORT

Johnson & Johnson: Pipeline, Products, Performance, Potential

Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches, Retail Clinics, Prescribing Pharmacists, The Growing Out of Pocket Healthcare Market)

Key Trends in the Political and Reimbursement Environment for Cancer Drugs

Life Sciences Funding in Europe (2007)

Navigating the Drug Discovery Landscape: A Strategic Overview of Pharmaceutical R&D

Opportunities and Challenges for Generic Drugs in Australia

Pharmaceutical Supply chain strategies: Reassessing product distribution to cut costs and improve supply chain management

Pharmacy Automation: Technologies and Global Markets

Pipeline and Commercial Insight: Alzheimer's Disease - Scenario forecasts reveal vast market potential

RFID in Pharmaceutical Manufacturing

Rheumatoid Arthritis Drug Discoveries: what the future holds

Sleep Disorders Market Analysis 2008-2018

SPECIAL REPORT: Pharmaceutical Pricing and Reimbursement in Germany, 2008

Stakeholder Opinions: Biologics in Infectious Diseases - Well defined target populations are key to commercial success

Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agents

Stakeholder Opinions: Sepsis - The Critical Care Community Gains Critical Mass

Stakeholder Opinions: Systemic Lupus Erythematosus - Market set to enter era of biologic therapies

Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

Target Product Profiles: Physician Insights on Key Attributes - Acute Ischemic Stroke, IV reperfusion agent approved for use within six hours of acute ischemic stroke.

Target Product Profiles: Physician Insights on Key Attributes - Alzheimer's Disease

Target Product Profiles: Physician Insights on Key Attributes - Asthma, An inhaled drug with a novel mechanism of action for the treatment of persistent asthma

Target Product Profiles: Physician Insights on Key Attributes - Benign Prostatic Hyperplasia, A drug with lower incidence of sexual side effects than tamsulosin for the treatment of benign prostatic hyperplasia.

Target Product Profiles: Physician Insights on Key Attributes - Bipolar Disorder, A therapy that carries a lower risk of weight gain than quetiapine and has both antimanic and antidepressant effects for the treatment of bipolar disorder.

Target Product Profiles: Physician Insights on Key Attributes - Chemotherapy-Induced Nausea and Vomiting

Target Product Profiles: Physician Insights on Key Attributes - Colon Cancer (Stage III), A therapy that improves disease-free survival over FOLFOX4 at three years for the treatment of stage III colon cancer

Target Product Profiles: Physician Insights on Key Attributes - Colorectal Cancer (Stage IV), A therapy that improves median overall survival better than the IFL plus bevacizumab regimen for the first-line treatment of stage IV colorectal cancer

Target Product Profiles: Physician Insights on Key Attributes - Community-Acquired Pneumonia, An antibiotic with targeted activity against respiratory pathogens that does not affect bowel flora for the treatment of community-acquired pneumonia.

Target Product Profiles: Physician Insights on Key Attributes - Crohn's Disease, A parenterally dosed therapy that induces closure and healing of fistulas in a greater percentage of Crohn's disease patients than infliximab does.

Target Product Profiles: Physician Insights on Key Attributes - Diabetic Nephropathy, A therapy that is more effective than irbesartan in inducing regression from microalbuminuria to normoalbuminuria for the treatment of diabetic nephropathy

Target Product Profiles: Physician Insights on Key Attributes - Diabetic Neuropathy, An agent offering pain relief superior to that of pregabalin

Target Product Profiles: Physician Insights on Key Attributes - Diabetic Retinopathy

Target Product Profiles: Physician Insights on Key Attributes - Dyslipidemia, An HDL-raising drug that has a lower discontinuation rate than extended-release (ER) niacin for the treatment of dyslipidemia.

Target Product Profiles: Physician Insights on Key Attributes - Fibromyalgia

Target Product Profiles: Physician Insights on Key Attributes - Hepatitis C Virus

Target Product Profiles: Physician Insights on Key Attributes - Insomnia, A hypnotic that is free of next-day residual effects for the treatment of insomnia

Target Product Profiles: Physician Insights on Key Attributes - Major Depressive Disorder, A therapy that can prevent recurrence of major depressive disorder in a greater percentage of patients than venlafaxine XR does at one year.

Target Product Profiles: Physician Insights on Key Attributes - Mild Cognitive Impairment, A therapy that improves ADAS-cog score from baseline at 12 months for the treatment of mild cognitive impairment.